NASDAQ:BLUE Shareholder Notice: Lawsuit Alleges Misleading Statements by Bluebird Bio Inc
February 24, 2021 at 13:00 PM EST
San Diego, CA -- (SBWIRE) -- 02/24/2021 -- An investor, who purchased shares of bluebird bio Inc (NASDAQ:BLUE), filed a lawsuit over alleged violations of Federal Securities Laws by bluebird bio Inc.
